Drug intelligence / Profile preview

gabapentin + oxycodone

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Gabapentin + oxycodone is a combination therapy used primarily for the management of moderate to severe pain, especially when pain has both neuropathic and nociceptive components. Gabapentin is an anticonvulsant that modulates nerve signaling to reduce neuropathic pain, while oxycodone is an opioid analgesic that acts on mu, kappa, and delta opioid receptors in the central nervous system to alter the perception of pain. This combination can provide enhanced analgesia compared to either drug alone and may allow for lower doses of opioids, reducing some opioid-related side effects such as nausea, vomiting, and constipation. However, concurrent use increases risks such as sedation and respiratory depression; therefore, close monitoring is required[1][2][5][8].

Other names
gabapentin and oxycodoneoxycodone and gabapentin
02

Targets

DOR (Opioid Receptor Delta 1)CACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)KOR (Kappa opioid receptor)α2δ (Voltage-gated calcium channel alpha-2-delta subunit)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on gabapentin + oxycodone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gabapentin + oxycodone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call